(Q51059202)

27 March 2018

title

Dramatic effects of eculizumab in a child with diffuse proliferative lupus nephritis resistant to conventional therapy. (English)

1 reference

27 March 2018

1 reference

10

1 reference

27 March 2018

Pier Angelo Tovo

object named as

Pier Angelo Tovo

9

0 references

Arrigo Schieppati

7

object named as

Arrigo Schieppati

1 reference

27 March 2018

author name string

Rosanna Coppo

1

1 reference

27 March 2018

Licia Peruzzi

2

1 reference

27 March 2018

Alessandro Amore

3

1 reference

27 March 2018

Silvana Martino

4

1 reference

27 March 2018

Luca Vergano

5

1 reference

27 March 2018

Inna Lastauka

6

1 reference

27 March 2018

Marina Noris

8

1 reference

27 March 2018

publication date

31 August 2014

1 reference

27 March 2018

published in

Pediatric Nephrology

1 reference

27 March 2018

volume

30

1 reference

27 March 2018

issue

1

1 reference

27 March 2018

page(s)

167-172

1 reference

27 March 2018

https://scigraph.springernature.com/pub.10.1007/s00467-014-2944-y

exact match

0 references

cites work

The pathogenesis of lupus nephritis.

1 reference

https://api.crossref.org/works/10.1007%2FS00467-014-2944-Y

Complement, interferon and lupus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-014-2944-Y

Monogenic forms of systemic lupus erythematosus: new insights into SLE pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-014-2944-Y

Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-014-2944-Y

Targeting the complement system in systemic lupus erythematosus and other diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-014-2944-Y

Amelioration of lupus-like autoimmune disease in NZB/WF1 mice after treatment with a blocking monoclonal antibody specific for complement component C5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-014-2944-Y

The 1982 revised criteria for the classification of systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-014-2944-Y

Atypical hemolytic-uremic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-014-2944-Y

The benefit of targeted and selective inhibition of the alternative complement pathway for modulating autoimmunity and renal disease in MRL/lpr mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-014-2944-Y

Lupus nephritis combined with renal injury due to thrombotic thrombocytopaenic purpura-haemolytic uraemic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-014-2944-Y

Eculizumab in atypical hemolytic uremic syndrome: long-term clinical course and histological findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-014-2944-Y

How I treat paroxysmal nocturnal hemoglobinuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-014-2944-Y

Eculizumab in the treatment of atypical hemolytic uremic syndrome in infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-014-2944-Y

Rituximab: rescue therapy in life-threatening complications or refractory autoimmune diseases: a single center experience

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25173358

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S00467-014-2944-Y

1 reference

27 March 2018

1 reference

27 March 2018